Expensive New Cancer Drugs Drive Explosive Spending Growth

From Business Insider:

Charlotte Hu is reporting in Business Insider that a new study released by the IQVIA Institute for Human Data Science states that, In the US alone, spending on cancer medicine doubled over the last five years from $25 billion to $50 billion.

The median annual cost of a cancer drug launched in 2017 exceeded $150,000. Read more.